Israeli genealogy co MyHeritage to launch DNA health test

Gilad Japhet
Gilad Japhet

The test provides a new dimension of genetic insight with comprehensive health reports that can empower future health and lifestyle choices.

Israeli genealogy and family history company MyHeritage announced today a major expansion of its DNA product line with the launch of the MyHeritage DNA Health+Ancestry test. The test provides a new dimension of genetic insight with comprehensive health reports that can empower future health and lifestyle choices.

The new test is a superset of the current MyHeritage DNA Ancestry-Only test, and includes its pillar features: a percentage breakdown of ethnic origins and matching to relatives through shared DNA. MyHeritage is now the only global consumer DNA company to offer an extensive health and ancestry product in over 40 languages.

The launch of the Health+Ancestry product distinguishes MyHeritage as a major service that bridges consumers’ past, present, and future: MyHeritage’s integrated suite of products enable users to discover their family history and ethnic origins, find new relatives, and receive valuable insights to help manage choices regarding their health that may impact their future well-being.

MyHeritage founder and CEO Gilad Japhet said, "Our Health+Ancestry test is the next step in the evolution of MyHeritage. After 16 years of changing lives for the better through family history research and genetic genealogy, we are excited to expand our mission and try to improve and save lives as well. Our vision is to integrate our successful family history technologies with the new health product in innovative ways that bridge heritage and heredity to deliver deeper insights for our users. We are proud to be part of a movement to democratize healthcare globally and make genetic testing accessible to millions of people, and allow them to discover what makes them unique."

The MyHeritage DNA Health+Ancestry test provides health reports that show users their risk of developing or carrying genetic conditions. Reports include conditions where specific genes contribute to the risk, such as hereditary breast cancer, late-onset Alzheimer’s disease, and late-onset Parkinson’s disease; conditions associated with multiple genes, such as heart disease, and type 2 diabetes; and carrier status reports on conditions that can be passed down from a couple to their children, such as Tay-Sachs disease and cystic fibrosis.

MyHeritage’s Health+Ancestry test covers one of the most extensive ranges of conditions offered by an at-home DNA test: 11 Genetic Risk Reports, including a hereditary breast cancer (BRCA) report that tests 10 pathogenic variants; 3 Polygenic Risk Reports; and 15 Carrier Status Reports.

The Health+Ancestry product also includes a Polygenic Risk Score for type 2 diabetes.

Published by Globes, Israel business news - en.globes.co.il - on May 20, 2019

© Copyright of Globes Publisher Itonut (1983) Ltd. 2019

Gilad Japhet
Gilad Japhet
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018